Signifier Medical Technologies announces a landmark order of 10,000 eXciteOSA devices from leading home medical equipment provider, Spectrum Sleep Solutions Inc.

BOSTON, June 11, 2024–(BUSINESS WIRE)–Signifier Medical Technologies Limited (“Signifier” and the “Company”), a medical technology leader specializing in sleep apnea therapy solutions, is pleased to announce its largest ever order. Spectrum Sleep Solutions Inc. placed a huge order for 10,000 pieces of the innovative eXciteOSA device. This significant order follows eXciteOSA’s inclusion in South Carolina’s Human and Health Services Medicaid program, an important step toward increasing access to and treatment for people suffering from sleep apnea.

The size of the order only shows how far the Company has come since its establishment, and especially since last year’s restructuring. Since August 2023, under new and dynamic management, supported by a functional new Management Board, the Company has achieved a number of commercial successes previously unheard of in the Company.

eXciteOSA is an innovative therapy for obstructive sleep apnea (OSA), offering a non-invasive approach to the treatment of this disease. Unlike traditional continuous positive airway pressure (CPAP) devices, eXciteOSA uses neuromuscular electrical therapy (NMES) to increase the strength of the muscles at the back of the tongue, reducing the risk of airway collapse during sleep. With eXciteOSA prescribed to over 15,000 patients and real-world data showing strict compliance with patients using the therapy on 80% of days, this innovative therapy allows patients to complete sessions for just 20 minutes during the day, giving them the freedom to breathe naturally throughout the night, alone.

“I am delighted that discussions between Signifier and Spectrum Sleep Solutions have resulted in Signifier delivering its largest ever commercial order, which becomes increasingly important as it follows a period of deep business consolidation, deepening our links with technology to increase efficiencies while deploying capital in expanding our supply chain. We are building a leading team led by Signifier’s eXciteOSA expert Yasser Zayni, in partnership with Spectrum Sleep Solutions and their established clinical channel development strategies”, exclaimed Mujtaba Chohan, CFO and CEO of Signifier. “Spectrum Sleep Solutions’ decision to use eXciteOSA highlights its effectiveness and ability to revolutionize the treatment of sleep apnea.“

Akhil Tripathi, Founder and Director of Signifier, stated: “This milestone, which is the result of recent Medicaid coverage in South Carolina, reflects our ongoing mission to expand access to innovative therapies for people in need. Spectrum Sleep Solutions, a leading U.S. medical distributor, shares Signifier’s vision for eXciteOSA to become the de facto first-line therapy for the treatment of sleep apnea and is the first in a series of related transactions that Spectrum Sleep Solutions is committed to continuing to deepen its relations with the Company.“

Spectrum Sleep Solutions’ order highlights the growing need for alternative therapies to treat OSA and underscores the importance of expanding access to innovative treatment options. This significant order supports Spectrum Sleep Solutions’ commitment to providing its customers with effective sleep apnea treatments and reinforces Signifier’s role as a leader in this field.

Spectrum Sleep Solutions CEO Forrest Ackerman states, “The partnership with Signifier is an important step in our commitment to offer innovative and effective solutions for the treatment of sleep apnea and to treat the hundreds of thousands of patients who need effective and clinically proven alternative therapies for sleep-disordered breathing. eXciteOSA therapy provides a non-invasive alternative that aligns with our mission to improve patient outcomes and overall quality of life. We look forward to growing our relationship with the company in the coming years and developing the product through our commercial channels throughout the United States, making we can positively impact the health and well-being of our patients.”

Signifier looks forward to continuing to work with Spectrum Sleep Solutions and other healthcare partners as they work to expand the availability of the eXciteOSA device in the United States and beyond.

To learn more about eXciteOSA, visit www.signifiermedical.com or www.exciteosa.com.

About Signifier Health Technologies

Signifier is a pioneer in addressing the root causes of sleep-disordered breathing. The company focuses on developing and commercializing innovative and non-invasive solutions that help people breathe normally and naturally throughout the night – without the need for a portable medical device or surgical implant. Founded in 2015, Signifier is a leader in sleep therapy with a mission to develop therapies that improve population health, improve patient health care, and generate health care savings. Signifier has offices in London (UK) and Needham (Massachusetts, USA).

About eXciteOSA®

eXciteOSA is a revolutionary daily therapy for sleep-related breathing disorders. Clinically proven to address the common cause of OSA, eXciteOSA uses NMES to “exercise” the upper airway muscles, working the inner and outer tongue muscles to improve endurance and prevent the airway from collapsing during sleep. Unlike other sleep devices, eXciteOSA is the first sleep device on the market.

Signifier is committed to working with the sleep research community to obtain high-quality evidence from rigorous clinical trials.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240610716059/en/

Communication

Media:
Jay Cranston
Signifier Medical Technologies Limited
[email protected]

Investors and partners:
Investor Relations
Signifier Medical Technologies Limited
[email protected]